| Year |
Citation |
Score |
| 2024 |
Aydin J, Gabel A, Zielinski S, Ganskih S, Schmidt N, Hartigan CR, Schenone M, Carr SA, Munschauer M. SHIFTR enables the unbiased identification of proteins bound to specific RNA regions in live cells. Nucleic Acids Research. PMID 38281241 DOI: 10.1093/nar/gkae038 |
0.279 |
|
| 2024 |
Zhu QM, Hsu YH, Lassen FH, MacDonald BT, Stead S, Malolepsza E, Kim A, Li T, Mizoguchi T, Schenone M, Guzman G, Tanenbaum B, Fornelos N, Carr SA, Gupta RM, et al. Protein interaction networks in the vasculature prioritize genes and pathways underlying coronary artery disease. Communications Biology. 7: 87. PMID 38216744 DOI: 10.1038/s42003-023-05705-1 |
0.27 |
|
| 2023 |
Nagai TH, Hartigan C, Mizoguchi T, Yu H, Deik A, Bullock K, Wang Y, Cromley D, Schenone M, Cowan CA, Rader DJ, Clish CB, Carr SA, Xu YX. Chromatin regulator SMARCAL1 modulates cellular lipid metabolism. Communications Biology. 6: 1298. PMID 38129665 DOI: 10.1038/s42003-023-05665-6 |
0.273 |
|
| 2023 |
Conole D, Cao F, Am Ende CW, Xue L, Kantesaria S, Kang D, Jin J, Owen D, Lohr L, Schenone M, Majmudar JD, Tate EW. Discovery of a Potent Deubiquitinase (DUB) Small-Molecule Activity-Based Probe Enables Broad Spectrum DUB Activity Profiling in Living Cells. Angewandte Chemie (International Ed. in English). 62: e202311190. PMID 37779326 DOI: 10.1002/anie.202311190 |
0.344 |
|
| 2023 |
Xu J, Kong L, Oliver BA, Li B, Creasey EA, Guzman G, Schenone M, Carey KL, Carr SA, Graham DB, Deguine J, Xavier RJ. Constitutively active autophagy in macrophages dampens inflammation through metabolic and post-transcriptional regulation of cytokine production. Cell Reports. 42: 112708. PMID 37392388 DOI: 10.1016/j.celrep.2023.112708 |
0.289 |
|
| 2023 |
Hsu YH, Pintacuda G, Liu R, Nacu E, Kim A, Tsafou K, Petrossian N, Crotty W, Suh JM, Riseman J, Martin JM, Biagini JC, Mena D, Ching JKT, Malolepsza E, ... ... Schenone M, et al. Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophrenia. Iscience. 26: 106701. PMID 37207277 DOI: 10.1016/j.isci.2023.106701 |
0.248 |
|
| 2021 |
Schaefer EJ, Wang HC, Karp HQ, Meyer CA, Cejas P, Gearhart MD, Adelman ER, Fares I, Apffel A, Lim K, Xie Y, Gibson CJ, Schenone M, Murdock HM, Wang ES, et al. BCOR and BCORL1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking PRC1.1 from target genes. Blood Cancer Discovery. PMID 35015684 DOI: 10.1158/2643-3230.BCD-21-0115 |
0.323 |
|
| 2021 |
Beauchamp EM, Leventhal M, Bernard E, Hoppe ER, Todisco G, Creignou M, Gallì A, Castellano CA, McConkey M, Tarun A, Wong W, Schenone M, Stanclift C, Tanenbaum B, Malolepsza E, et al. is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing. Blood Cancer Discovery. 2: 500-517. PMID 34568833 DOI: 10.1158/2643-3230.BCD-20-0224 |
0.281 |
|
| 2021 |
Adane B, Alexe G, Seong BKA, Lu D, Hwang EE, Hnisz D, Lareau CA, Ross L, Lin S, Dela Cruz FS, Richardson M, Weintraub AS, Wang S, Iniguez AB, Dharia NV, ... ... Schenone M, et al. STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma. Cancer Cell. 39: 827-844.e10. PMID 34129824 DOI: 10.1016/j.ccell.2021.05.007 |
0.308 |
|
| 2021 |
Touchette MH, Benito de la Puebla H, Alves Feliciano C, Tanenbaum B, Schenone M, Carr SA, Shen A. Identification of a Novel Regulator of Clostridioides difficile Cortex Formation. Msphere. 6: e0021121. PMID 34047655 DOI: 10.1128/mSphere.00211-21 |
0.284 |
|
| 2021 |
Roux B, Vaganay C, Vargas JD, Alexe G, Benaksas C, Pardieu B, Fenouille N, Ellegast JM, Malolepsza E, Ling F, Sodaro G, Ross L, Pikman Y, Conway AS, Tang Y, ... ... Schenone M, et al. Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor. Science Translational Medicine. 13. PMID 33790022 DOI: 10.1126/scitranslmed.abg1168 |
0.345 |
|
| 2021 |
Belizaire R, Koochaki SHJ, Udeshi ND, Vedder A, Sun L, Svinkina T, Hartigan C, McConkey ME, Kovalcik V, Bizuayehu A, Stanclift C, Schenone M, Carr SA, Padron E, Ebert BL. CBL mutations drive PI3K/AKT signaling via increased interaction with LYN and PIK3R1. Blood. PMID 33512474 DOI: 10.1182/blood.2020006528 |
0.35 |
|
| 2020 |
Tothova Z, Valton AL, Gorelov R, Vallurupalli M, Krill-Burger JM, Holmes A, Landers CC, Haydu JE, Malolepsza E, Hartigan CR, Donahue M, Popova KD, Koochaki SHJ, Venev SV, Rivera JF, ... ... Schenone M, et al. Cohesin mutations alter DNA damage repair and chromatin structure and create therapeutic vulnerabilities in MDS/AML. Jci Insight. PMID 33351783 DOI: 10.1172/jci.insight.142149 |
0.325 |
|
| 2020 |
Xu YX, Stanclift C, Nagai TH, Yu H, Vellarikkal SK, Deik A, Bullock K, Schenone M, Cowan C, Clish CB, Carr S, Kathiresan S. Interactomics Analyses of Wild-Type and Mutant A1CF Reveal Diverged Functions in Regulating Cellular Lipid Metabolism. Journal of Proteome Research. PMID 32786677 DOI: 10.1021/Acs.Jproteome.0C00235 |
0.322 |
|
| 2020 |
Gupta M, Concepcion CP, Fahey CG, Keshishian H, Bhutkar A, Brainson CF, Sanchez-Rivera FJ, Pessina P, Kim JY, Simoneau A, Paschini M, Beytagh MC, Stanclift CR, Schenone M, Mani DR, et al. BRG1 loss predisposes lung cancers to replicative stress and ATR dependency. Cancer Research. PMID 32690724 DOI: 10.1158/0008-5472.Can-20-1744 |
0.288 |
|
| 2020 |
Gandhi M, Groß M, Holler JM, Coggins SA, Patil N, Leupold JH, Munschauer M, Schenone M, Hartigan CR, Allgayer H, Kim B, Diederichs S. The lncRNA lincNMR regulates nucleotide metabolism via a YBX1 - RRM2 axis in cancer. Nature Communications. 11: 3214. PMID 32587247 DOI: 10.1038/S41467-020-17007-9 |
0.311 |
|
| 2020 |
Basak A, Munschauer M, Lareau CA, Montbleau KE, Ulirsch JC, Hartigan CR, Schenone M, Lian J, Wang Y, Huang Y, Wu X, Gehrke L, Rice CM, An X, Christou HA, et al. Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation. Nature Genetics. PMID 31959994 DOI: 10.1038/S41588-019-0568-7 |
0.334 |
|
| 2019 |
Bandopadhayay P, Piccioni F, O'Rourke R, Ho P, Gonzalez EM, Buchan G, Qian K, Gionet G, Girard E, Coxon M, Rees MG, Brenan L, Dubois F, Shapira O, Greenwald NF, ... ... Schenone M, et al. Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma. Nature Communications. 10: 2400. PMID 31160565 DOI: 10.1038/S41467-019-10307-9 |
0.306 |
|
| 2019 |
Chan EM, Shibue T, McFarland JM, Gaeta B, Ghandi M, Dumont N, Gonzalez A, McPartlan JS, Li T, Zhang Y, Bin Liu J, Lazaro JB, Gu P, Piett CG, Apffel A, ... ... Schenone M, et al. WRN helicase is a synthetic lethal target in microsatellite unstable cancers. Nature. PMID 30971823 DOI: 10.1038/S41586-019-1102-X |
0.302 |
|
| 2019 |
Belizaire R, Koochaki S, Udeshi N, Vedder A, Sun L, Schenone M, Carr S, Padron E, Ebert BL. Oncogenic Mechanisms of CBL E3 Ubiquitin Ligase Mutations in Myeloid Malignancies Blood. 134: 563-563. DOI: 10.1182/Blood-2019-122503 |
0.355 |
|
| 2018 |
McCoull W, Cheung T, Anderson E, Barton P, Burgess J, Byth K, Cao Q, Castaldi MP, Chen H, Chiarparin E, Carbajo RJ, Code E, Cowan S, Davey PR, Ferguson AD, ... ... Schenone M, et al. Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6. Acs Chemical Biology. PMID 30335946 DOI: 10.1021/Acschembio.8B00698 |
0.319 |
|
| 2018 |
Mortison JD, Schenone M, Myers JA, Zhang Z, Chen L, Ciarlo C, Comer E, Natchiar SK, Carr SA, Klaholz BP, Myers AG. Tetracyclines Modify Translation by Targeting Key Human rRNA Substructures. Cell Chemical Biology. PMID 30318461 DOI: 10.1016/J.Chembiol.2018.09.010 |
0.374 |
|
| 2018 |
Munschauer M, Nguyen CT, Sirokman K, Hartigan CR, Hogstrom L, Engreitz JM, Ulirsch JC, Fulco CP, Subramanian V, Chen J, Schenone M, Guttman M, Carr SA, Lander ES. The NORAD lncRNA assembles a topoisomerase complex critical for genome stability. Nature. PMID 30150775 DOI: 10.1038/s41586-018-0453-z |
0.33 |
|
| 2018 |
Sandoval GJ, Pulice JL, Pakula H, Schenone M, Takeda DY, Pop M, Boulay G, Williamson KE, McBride MJ, Pan J, St Pierre R, Hartman E, Garraway LA, Carr SA, Rivera MN, et al. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis. Molecular Cell. PMID 30078722 DOI: 10.1016/J.Molcel.2018.06.040 |
0.307 |
|
| 2018 |
Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, Stern AM, Mandinova A, Schreiber SL, Lee SW. Retraction Note: Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature. PMID 30046103 DOI: 10.1038/S41586-018-0284-Y |
0.244 |
|
| 2018 |
Jin YN, Schlueter PJ, Jurisch-Yaksi N, Lam PY, Jin S, Hwang WY, Yeh JJ, Yoshigi M, Ong SE, Schenone M, Hartigan CR, Carr SA, Peterson RT. Noncanonical translation via deadenylated 3' UTRs maintains primordial germ cells. Nature Chemical Biology. PMID 29988067 DOI: 10.1038/S41589-018-0098-0 |
0.281 |
|
| 2018 |
Viswanathan SR, Nogueira MF, Buss CG, Krill-Burger JM, Wawer MJ, Malolepsza E, Berger AC, Choi PS, Shih J, Taylor AM, Tanenbaum B, Pedamallu CS, Cherniack AD, Tamayo P, Strathdee CA, ... ... Schenone M, et al. Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer. Nature Genetics. PMID 29955178 DOI: 10.1038/S41588-018-0155-3 |
0.313 |
|
| 2018 |
Mohanan V, Nakata T, Desch AN, Lévesque C, Boroughs A, Guzman G, Cao Z, Creasey E, Yao J, Boucher G, Charron G, Bhan AK, Schenone M, Carr SA, Reinecker HC, et al. C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. Science (New York, N.Y.). PMID 29420262 DOI: 10.1126/Science.Aan0814 |
0.271 |
|
| 2018 |
Schaefer EJ, Fares I, Meyer C, Cejas P, Apffel A, Schenone M, Long HW, Lindsley RC. Dual Effects of BCOR-PRC1.1 Dependent Gene Regulation Mediate Cooperation of BCOR and TET2 Mutations in Myeloid Transformation Blood. 132: 651-651. DOI: 10.1182/Blood-2018-99-119519 |
0.373 |
|
| 2018 |
Tothova Z, Krill-Burger JM, Day DS, Haydu JE, Abraham BJ, Landers CC, Malolepsza E, Hartigan CR, Holmes A, Donahue M, Popova KD, Koochaki S, Rivera J, Seiler M, Hnisz D, ... ... Schenone M, et al. STAG2 Mutations Alter Cohesin Ring Function and Provide Therapeutic Vulnerabilities in Acute Myeloid Leukemia Blood. 132: 940-940. DOI: 10.1182/Blood-2018-99-117480 |
0.356 |
|
| 2018 |
Basak A, Munschauer M, Ulirsch JC, Montbleau KE, Hartigan CR, Schenone M, Lian J, Wang Y, Huang Y, Wu X, Gehrke L, Rice CM, An X, Christou HA, Narla M, et al. Control of Human Hemoglobin Switching By LIN28B-Mediated Regulation of BCL11A Translation Blood. 132: 412-412. DOI: 10.1182/Blood-2018-99-117440 |
0.345 |
|
| 2017 |
Rusu V, Hoch E, Mercader JM, Tenen DE, Gymrek M, Hartigan CR, DeRan M, von Grotthuss M, Fontanillas P, Spooner A, Guzman G, Deik AA, Pierce KA, Dennis C, Clish CB, ... ... Schenone M, et al. Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms. Cell. 170: 199-212.e20. PMID 28666119 DOI: 10.1016/J.Cell.2017.06.011 |
0.276 |
|
| 2017 |
Fulciniti M, Martinez-Lopez J, Senapedis W, Oliva S, Bandi RL, Amodio N, Xu Y, Szalat RL, Gulla A, Samur MK, Roccaro A, Linares M, Cea M, Baloglu E, Argueta C, ... ... Schenone M, et al. Functional role and therapeutic targeting of p21-associated kinase 4 (PAK4) in multiple myeloma. Blood. PMID 28096095 DOI: 10.1182/Blood-2016-06-724831 |
0.314 |
|
| 2016 |
Graham DB, Lefkovith A, Deelen P, de Klein N, Varma M, Boroughs A, Desch AN, Ng AC, Guzman G, Schenone M, Petersen CP, Bhan AK, Rivas MA, Daly MJ, Carr SA, et al. TMEM258 Is a Component of the Oligosaccharyltransferase Complex Controlling ER Stress and Intestinal Inflammation. Cell Reports. 17: 2955-2965. PMID 27974209 DOI: 10.1016/J.Celrep.2016.11.042 |
0.268 |
|
| 2016 |
Choudhury AD, Schinzel AC, Cotter MB, Lis RT, Labella K, Lock YJ, Izzo F, Guney I, Bowden M, Li YY, Patel J, Hartman E, Carr SA, Schenone M, Jaffe JD, et al. Castration resistance in prostate cancer is mediated by the kinase NEK6. Cancer Research. PMID 27899381 DOI: 10.1158/0008-5472.Can-16-0455 |
0.278 |
|
| 2016 |
Schneider RK, Schenone M, Ferreira MV, Kramann R, Joyce CE, Hartigan C, Beier F, Brümmendorf TH, Germing U, Platzbecker U, Büsche G, Knüchel R, Chen MC, Waters CS, Chen E, et al. Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9. Nature Medicine. PMID 26878232 DOI: 10.1038/Nm.4047 |
0.318 |
|
| 2015 |
de Waal L, Lewis TA, Rees MG, Tsherniak A, Wu X, Choi PS, Gechijian L, Hartigan C, Faloon PW, Hickey MJ, Tolliday N, Carr SA, Clemons PA, Munoz B, Wagner BK, ... ... Schenone M, et al. Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics. Nature Chemical Biology. PMID 26656089 DOI: 10.1038/Nchembio.1984 |
0.326 |
|
| 2015 |
Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, Stern AM, Mandinova A, Schreiber SL, Lee SW. Corrigendum: Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature. PMID 26375002 DOI: 10.1038/Nature15370 |
0.256 |
|
| 2015 |
Begun J, Lassen KG, Jijon HB, Baxt LA, Goel G, Heath RJ, Ng A, Tam JM, Kuo SY, Villablanca EJ, Fagbami L, Oosting M, Kumar V, Schenone M, Carr SA, et al. Integrated Genomics of Crohn's Disease Risk Variant Identifies a Role for CLEC12A in Antibacterial Autophagy. Cell Reports. 11: 1905-18. PMID 26095365 DOI: 10.1016/J.Celrep.2015.05.045 |
0.319 |
|
| 2015 |
Chou DH, Vetere A, Choudhary A, Scully SS, Schenone M, Tang A, Gomez R, Burns SM, Lundh M, Vital T, Comer E, Faloon PW, Dan?ík V, Ciarlo C, Paulk J, et al. Kinase-Independent Small-Molecule Inhibition of JAK-STAT Signaling. Journal of the American Chemical Society. 137: 7929-34. PMID 26042473 DOI: 10.1021/Jacs.5B04284 |
0.334 |
|
| 2015 |
Schneider R, Schenone M, Chen M, Waters C, McConkey M, Lindsley R, Ebert B. 36 TERMINAL ERYTHROID DIFFERENTIATION DEFECT AND ACTIVATION OF THE INNATE IMMUNE SYSTEM IN MICE WITH RIBOSOMAL PROTEIN S14 HAPLOINSUFFICIENCY Leukemia Research. 39: S16. DOI: 10.1016/S0145-2126(15)30037-0 |
0.264 |
|
| 2014 |
Krönke J, Udeshi ND, Narla A, Grauman P, Hurst SN, McConkey M, Svinkina T, Heckl D, Comer E, Li X, Ciarlo C, Hartman E, Munshi N, Schenone M, Schreiber SL, et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science (New York, N.Y.). 343: 301-5. PMID 24292625 DOI: 10.1126/Science.1244851 |
0.333 |
|
| 2014 |
Raiser DM, Schenone M, Hartman E, Carr SA, Ebert BL. A Proteomics Screen Identifies MDM2 Binding Partners Specific to Ribosomal Protein Haploinsufficiency Blood. 124: 1597-1597. DOI: 10.1182/blood.v124.21.1597.1597 |
0.39 |
|
| 2014 |
Senapedis W, Landesman Y, Schenone M, Karger B, Wu S, Shacham S, Baloglu E. 480 Identification of novel small molecules as selective PAK4 allosteric modulators (PAMs) by stable isotope labeling of amino acids in cells (SILAC) European Journal of Cancer. 50: 156. DOI: 10.1016/S0959-8049(14)70606-9 |
0.283 |
|
| 2013 |
Schenone M, Dan?ík V, Wagner BK, Clemons PA. Target identification and mechanism of action in chemical biology and drug discovery. Nature Chemical Biology. 9: 232-40. PMID 23508189 DOI: 10.1038/Nchembio.1199 |
0.309 |
|
| 2013 |
Krönke J, Udeshi N, Narla A, Grauman P, Hurst S, McConkey M, Svinkina T, Heckl D, Comer E, Li X, Ciarlo C, Hartman E, Schenone M, Schreiber S, Carr SA, et al. Lenalidomide Promotes CRBN-Mediated Ubiquitination and Degradation of IKZF1 and IKZF3 Blood. 122: LBA-5-LBA-5. DOI: 10.1182/Blood.V122.21.Lba-5.Lba-5 |
0.396 |
|
| 2012 |
Wen Q, Goldenson B, Silver SJ, Schenone M, Dancik V, Huang Z, Wang LZ, Lewis TA, An WF, Li X, Bray MA, Thiollier C, Diebold L, Gilles L, Vokes MS, et al. Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL. Cell. 150: 575-89. PMID 22863010 DOI: 10.1016/J.Cell.2012.06.032 |
0.334 |
|
| 2012 |
Ong SE, Li X, Schenone M, Schreiber SL, Carr SA. Identifying cellular targets of small-molecule probes and drugs with biochemical enrichment and SILAC. Methods in Molecular Biology (Clifton, N.J.). 803: 129-40. PMID 22065222 DOI: 10.1007/978-1-61779-364-6_9 |
0.311 |
|
| 2012 |
Krönke J, Narla A, Hurst SN, Udeshi N, Schenone M, McConkey M, Grauman P, Heckl D, McAuley R, Ciarlo C, Comer E, Li X, Carr SA, Ebert BL. Inhibition of the CRBN-DDB1-CUL4-ROC1 E3 Ubiquitin Ligase Mediates the Anti-Proliferative and Immunomodulatory Properties of Lenalidomide Blood. 120: 919-919. DOI: 10.1182/Blood.V120.21.919.919 |
0.386 |
|
| 2011 |
Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, Stern AM, Mandinova A, Schreiber SL, Lee SW. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature. 475: 231-4. PMID 21753854 DOI: 10.1038/Nature10167 |
0.326 |
|
| 2009 |
Margolin AA, Ong SE, Schenone M, Gould R, Schreiber SL, Carr SA, Golub TR. Empirical Bayes analysis of quantitative proteomics experiments. Plos One. 4: e7454. PMID 19829701 DOI: 10.1371/Journal.Pone.0007454 |
0.282 |
|
| 2009 |
Ong SE, Schenone M, Margolin AA, Li X, Do K, Doud MK, Mani DR, Kuai L, Wang X, Wood JL, Tolliday NJ, Koehler AN, Marcaurelle LA, Golub TR, Gould RJ, et al. Identifying the proteins to which small-molecule probes and drugs bind in cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 4617-22. PMID 19255428 DOI: 10.1073/Pnas.0900191106 |
0.354 |
|
| 2009 |
Wen Q, Huang Z, Small S, Bubna N, An F, Bliss-Moreau M, Verplank L, Lewis T, Schenone M, Tolliday N, Moore C, Carpenter A, Mercher T, Levine RL, Izraeli S, et al. Identification of Inducers of Megakaryocyte Polyploidization and Their Use as Targeted Differentiation Therapy for Acute Megakaryocytic Leukemia. Blood. 114: 792-792. DOI: 10.1182/Blood.V114.22.792.792 |
0.358 |
|
| 2004 |
Schenone M, Furie BC, Furie B. The blood coagulation cascade Current Opinion in Hematology. 11: 272-277. PMID 15314527 DOI: 10.1097/01.Moh.0000130308.37353.D4 |
0.253 |
|
| 2002 |
Andoniades SE, Schenone M, Recondo EF, Fernández De Recondo ME. Influence of the degree of sulfation in the biological activity of dermatan sulfate and chondroitin sulfate C | Influencia del grado de sulfatación en la actividad biológica del dermatan sulfato y del condroitín sulfato C Anales Des La Asociacion Quimica Argentina. 90: 21-26. |
0.207 |
|
| 2001 |
Loy JA, Lin X, Schenone M, Castellino FJ, Zhang XC, Tang J. Domain interactions between streptokinase and human plasminogen. Biochemistry. 40: 14686-95. PMID 11724583 DOI: 10.1021/Bi011309D |
0.554 |
|
| 2001 |
Rios-Steiner JL, Schenone M, Mochalkin I, Tulinsky A, Castellino FJ. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein. Journal of Molecular Biology. 308: 705-19. PMID 11350170 DOI: 10.1006/Jmbi.2001.4646 |
0.588 |
|
| 2000 |
Schenone MM, Warder SE, Martin JA, Prorok M, Castellino FJ. An internal histidine residue from the bacterial surface protein, PAM, mediates its binding to the kringle-2 domain of human plasminogen. The Journal of Peptide Research : Official Journal of the American Peptide Society. 56: 438-45. PMID 11152303 DOI: 10.1034/J.1399-3011.2000.00810.X |
0.681 |
|
| 2000 |
Schenone MM, Warder SE, Martin JA, Prokok M, Castellino FJ. Binding of RAM-derived peptides to the recombinant kringle 2 domain of human plasminogen Fibrinolysis and Proteolysis. 14: 23. |
0.673 |
|
| Show low-probability matches. |